Literature DB >> 17446466

Functional importance of PMCA isoforms in growth and development of PC12 cells.

Ludmila Zylinska1, Anna Kozaczuk, Janusz Szemraj, Christos Kargas, Iwona Kowalska.   

Abstract

Intracellular Ca2+ in neuronal cells is an essential regulatory ion responsible for excitability, synaptic plasticity, and neurite outgrowth. Plasma membrane calcium ATPase (PMCA) is the most sensitive enzyme in decreasing of the Ca2+ concentration. The diverse PMCA isoforms composition in the membranes suggests their specific function in the cell, and whereas PMCA1 and 4 appear to be ubiquitous, PMCA2 and 3 are characteristic isoforms for excitable cells. The aim of our study was to elucidate if and how the elimination of neuron-specific isoforms affects the pattern of cell growth and development. We have obtained stable-transfected PC12 cell lines with a suppressed expression of PMCA2, PMCA3, or both neuron-specific isoforms. The modified profile of PMCA generated considerable changes in morphology of examined PC12 lines, suggesting the activation of a differentiation process to pseudoneuronal phenotype. Experiments with Fura-2/AM-loaded cells revealed an increased cytosolic Ca2+ concentration in the cell lines with blocked PMCA2 isoform. The suppression of PMCA2 concomitantly altered expression of sarco/endoplasmic Ca2+-ATPase 2 isoform (SERCA2) at the protein level. Comparative flow cytometry analysis, using Annexin V/PI conjugate, showed the difference in the mean percentage of apoptotic cells in modified PC12 lines. Our data suggest that specific PMCA isoforms presence can regulate the intact cell development; however, it may involve multiple unidentified yet signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446466     DOI: 10.1196/annals.1387.008

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Gene expression pattern in PC12 cells with reduced PMCA2 or PMCA3 isoform: selective up-regulation of calmodulin and neuromodulin.

Authors:  Tomasz Boczek; Anna Kozaczuk; Bozena Ferenc; Michalina Kosiorek; Slawomir Pikula; Ludmila Zylinska
Journal:  Mol Cell Biochem       Date:  2011-09-13       Impact factor: 3.396

Review 2.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

3.  Plasma membrane Ca-ATPases in the nervous system during development and ageing.

Authors:  Ana M Mata; M Rosario Sepulveda
Journal:  World J Biol Chem       Date:  2010-07-26

4.  Regulation of GAP43/calmodulin complex formation via calcineurin-dependent mechanism in differentiated PC12 cells with altered PMCA isoforms composition.

Authors:  Tomasz Boczek; Bozena Ferenc; Malwina Lisek; Ludmila Zylinska
Journal:  Mol Cell Biochem       Date:  2015-06-05       Impact factor: 3.396

5.  NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.

Authors:  Michalina Kosiorek; Paulina Podszywalow-Bartnicka; Ludmila Zylinska; Slawomir Pikula
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

6.  Silencing of plasma membrane Ca2+-ATPase isoforms 2 and 3 impairs energy metabolism in differentiating PC12 cells.

Authors:  Tomasz Boczek; Malwina Lisek; Bozena Ferenc; Antoni Kowalski; Magdalena Wiktorska; Ludmila Zylinska
Journal:  Biomed Res Int       Date:  2014-09-07       Impact factor: 3.411

7.  Calcineurin/NFAT signaling represses genes Vamp1 and Vamp2 via PMCA-dependent mechanism during dopamine secretion by Pheochromocytoma cells.

Authors:  Michalina Kosiorek; Ludmila Zylinska; Krzysztof Zablocki; Slawomir Pikula
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Plasma membrane Ca2+-ATPase isoforms composition regulates cellular pH homeostasis in differentiating PC12 cells in a manner dependent on cytosolic Ca2+ elevations.

Authors:  Tomasz Boczek; Malwina Lisek; Bozena Ferenc; Antoni Kowalski; Dariusz Stepinski; Magdalena Wiktorska; Ludmila Zylinska
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.